Inventor · disambiguated record
Bertrand Victor Gilbert Georges
Also filed as: GEORGES BERTRAND · GEORGES BERTRAND V · GEORGES BERTRAND VICTOR GILBERT
20 granted patents·17 pending applications·170 citations·filing 2001–2025
95Inventor score
Files withALTIMMUNE UK LTD17BONNET DOMINIQUE5ALTIMMUNE INC4SPITFIRE PHARMA LLC4COMMISSARIAT ENERGIE ATOMIQUE2
Top patents by PatentIndex Score
37 records- 0195US11918645B2Vaccines against hepatitis B virusALTIMMUNE UK LTD·Filed 2022·Granted Mar 5, 2024·3 cites·18 claims
- 0293US11382969B2Vaccines against Hepatitis B virusALTIMMUNE UK LTD·Filed 2019·Granted Jul 12, 2022·5 cites·19 claims
- 0393US10155049B2Influenza antigen delivery vectors and constructsALTIMMUNE UK LTD·Filed 2016·Granted Dec 18, 2018·12 cites·15 claims
- 0493US7687455B2Antigen delivery vectors and constructsIMMUNE TARGETING SYSTEMS LTD·Filed 2005·Granted Mar 30, 2010·38 cites·28 claims
- 0592US11382968B2Coronavirus immunogenic compositions and uses thereofALTIMMUNE INC·Filed 2021·Granted Jul 12, 2022·9 cites·19 claims
- 0691US9962453B2Immunogenic compoundALTIMMUNE UK LTD·Filed 2014·Granted May 8, 2018·14 cites·17 claims
- 0791US8129333B2Antigen delivery vectors and constructsBONNET DOMINIQUE·Filed 2008·Granted Mar 6, 2012·13 cites·25 claims
- 0891US8110541B2Antigen delivery vectors and constructsBONNET DOMINIQUE·Filed 2010·Granted Feb 7, 2012·12 cites·14 claims
- 0991US8110540B2Antigen delivery vectors and constructsBONNET DOMINIQUE·Filed 2010·Granted Feb 7, 2012·13 cites·19 claims
- 1090US8759281B2Antigen delivery vectors and constructsBONNET DOMINIQUE·Filed 2012·Granted Jun 24, 2014·11 cites·22 claims
- 1189US8642531B2Influenza antigen delivery vectors and constructsBONNET DOMINIQUE·Filed 2008·Granted Feb 4, 2014·10 cites·33 claims
- 1287US10434183B2Immunogenic compoundALTIMMUNE UK LTD·Filed 2018·Granted Oct 8, 2019·4 cites·20 claims
- 1387US9446143B2Influenza antigen delivery vectors and constructsALTIMMUNE UK LTD·Filed 2013·Granted Sep 20, 2016·8 cites·10 claims
- 1485US11066353B2Antigen delivery vectors and constructsALTIMMUNE UK LTD·Filed 2014·Granted Jul 20, 2021·2 cites·19 claims
- 1585US10849984B2Immunogenic compoundALTIMMUNE UK LTD·Filed 2019·Granted Dec 1, 2020·3 cites·19 claims
- 1681US10300132B2Vaccines against hepatitis B virusALTIMMUNE UK LTD·Filed 2013·Granted May 28, 2019·4 cites·8 claims
- 1781US9119811B2Fluorocarbon-linked peptide formulationBROWN CARLTON BRADLEY·Filed 2011·Granted Sep 1, 2015·8 cites·13 claims
- 1878US2024042007A1Fluorocarbon-Linked Peptide FormulationALTIMMUNE UK LTD·Filed 2023·Application pending·0 cites
- 1977US2022073446A1Antigen Delivery Vectors and ConstructsALTIMMUNE UK LTD·Filed 2021·Application pending·0 cites
- 2076US10729759B2Fluorocarbon-linked peptide formulationALTIMMUNE UK LTD·Filed 2015·Granted Aug 4, 2020·1 cites·11 claims
- 2170US11648305B2Fluorocarbon-linked peptide formulationALTIMMUNE UK LTD·Filed 2020·Granted May 16, 2023·0 cites·8 claims
- 2269US2021145975A1Immunogenic compoundALTIMMUNE UK LTD·Filed 2020·Application pending·0 cites
- 2365US2021316000A9Influenza antigen delivery vectors and constructsALTIMMUNE UK LTD·Filed 2018·Application pending·0 cites
- 2460US2021260180A1Coronavirus immunogenic compositions and uses thereofALTIMMUNE INC·Filed 2021·Application pending·0 cites
- 2555US2016199469A1Oncology vaccineALTIMMUNE UK LTD·Filed 2014·Application pending·0 cites
- 2652US2021236623A1T-cell inducing vaccine composition combination and uses thereofALTIMMUNE INC·Filed 2019·Application pending·0 cites
- 2751US2020316211A1Locally acting toll-like receptor 7 (tlr7) and/or tlr8 agonist immunotherapy compounds and their usesALTIMMUNE UK LTD·Filed 2020·Application pending·0 cites
- 2850US2021260181A1Coronavirus immunogenic compositions and uses thereofALTIMMUNE INC·Filed 2021·Application pending·0 cites
- 2948US2024148879A1Glp-1r, gip-r and/or gcgr agonists, formulations, and methods of useSPITFIRE PHARMA LLC·Filed 2022·Application pending·0 cites
- 3048US2008299140A1Immunogenic Composition and Peptide Sequences for Prevention and Treatment of an Hsv ConditionUNIV CALIFORNIA·Filed 2003·Application pending·0 cites
- 3148US2025367263A9Therapeutic Regimens and Methods for Treatment of Cardiovascular Risk Factors using a GLP-1R and GCGR AgonistSPITFIRE PHARMA LLC·Filed 2023·Application pending·0 cites
- 3247US2024269238A1Therapeutic Regimens and Methods for Reducing Body Weight in a Subject with Fatty Liver Disease using a GLP-1R and GCGR AgonistSPITFIRE PHARMA LLC·Filed 2023·Application pending·0 cites
- 3342US2003194747A1Convergent combinatory peptide libraries and their use for vaccination against hepatitis c virusFiled 2001·Application pending·0 cites
- 3440US2010324829A1Method of selecting hla-dp4 ligands and the applications thereofCOMMISSARIAT ENERGIE ATOMIQUE·Filed 2010·Application pending·0 cites
- 3539US7718575B2Method of selecting HLA-DP4 ligands and the applications thereofCOMMISSARIAT ENERGIE ATOMIQUE·Filed 2002·Granted May 18, 2010·0 cites·12 claims
- 3635US2006110401A1Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereofMAILLERE BERNARD·Filed 2003·Application pending·0 cites
- 3735US2025288650A1Therapeutic Regimens and Methods for Reducing Body Weight and/or Serum Lipids using a GLP-1R and GCGR AgonistSPITFIRE PHARMA LLC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bertrand Victor Gilbert Georges files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →